欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/0367/002
药品名称Novopulmon 400 Novolizer
活性成分
    • budesonide 400.0 µg
剂型Inhalation powder
上市许可持有人Viatris Healthcare GmbH Lütticher Straße 5 53842 Troisdorf Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Austria (AT)
      Novolizer Budesonid Meda 400 Mikrogramm Pulver zur Inhalation
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • United Kingdom (Northern Ireland) (XI)
许可日期2005/07/26
最近更新日期2024/09/04
药物ATC编码
    • R03BA02 budesonide
申请类型
  • TypeLevel1:Line Extension
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Other [Article 10.1.(a)(iii), last paragraph]
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase